Information:
Fel:
ID
20547
Beskrivning
A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA); ODM derived from: https://clinicaltrials.gov/show/NCT00336713
Länk
https://clinicaltrials.gov/show/NCT00336713
Nyckelord
Versioner (1)
- 2017-03-02 2017-03-02 -
Uppladdad den
2 mars 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Depressive Disorder NCT00336713
Eligibility Depressive Disorder NCT00336713
- StudyEvent: Eligibility
Similar models
Eligibility Depressive Disorder NCT00336713
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Major Depressive Disorder | Recurrent major depressive episodes
Item
diagnosis of major depressive disorder, as defined by dsm-iv criteria and confirmed by the semi-structured mini international neuropsychiatric interview (mini), recurrent episode.
boolean
C1269683 (UMLS CUI [1])
C0154409 (UMLS CUI [2])
C0154409 (UMLS CUI [2])
Montgomery-Asberg Depression Rating Scale Questionnaire
Item
total score of 28 or less on the montgomery and asberg depression rating scale (madrs).
boolean
C4054475 (UMLS CUI [1])
Clinical Global Impression Questionnaire
Item
clinical global impression (cgi) severity score of less than 4.
boolean
C3639708 (UMLS CUI [1])
Depressive episode Duration
Item
duration of the current depressive episode less than 2 months or greater than 2 years.
boolean
C0349217 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Patients Elderly Mini-mental state examination
Item
elderly patients with a mini-mental state examination (mmse) total score <25.
boolean
C0030705 (UMLS CUI [1,1])
C0001792 (UMLS CUI [1,2])
C0451306 (UMLS CUI [1,3])
C0001792 (UMLS CUI [1,2])
C0451306 (UMLS CUI [1,3])
Bipolar Disorder | Psychotic Disorders
Item
patients with a history or presence of bipolar disorders or psychotic disorders.
boolean
C0005586 (UMLS CUI [1])
C0033975 (UMLS CUI [2])
C0033975 (UMLS CUI [2])
Substance Dependence | Substance Use Disorders | Nicotine Dependence | Caffeine dependence
Item
patients with alcohol dependence or abuse or substance dependence or abuse in the past 12 months except nicotine or caffeine dependence.
boolean
C0038580 (UMLS CUI [1])
C0038586 (UMLS CUI [2])
C0028043 (UMLS CUI [3])
C1386553 (UMLS CUI [4])
C0038586 (UMLS CUI [2])
C0028043 (UMLS CUI [3])
C1386553 (UMLS CUI [4])
Benzodiazepines days/week | Sedative hypnotics days/week
Item
benzodiazepine or sedative-hypnotic use greater than 2 days per week during the month prior to entry into the acute phase.
boolean
C0005064 (UMLS CUI [1,1])
C0677547 (UMLS CUI [1,2])
C3854290 (UMLS CUI [2,1])
C0677547 (UMLS CUI [2,2])
C0677547 (UMLS CUI [1,2])
C3854290 (UMLS CUI [2,1])
C0677547 (UMLS CUI [2,2])
Antipsychotic Agents | Fluoxetine | Monoamine Oxidase Inhibitors | Antidepressive Agents | Mood Stabilizer | Lithium | Anticonvulsants
Item
patients who have used the following prior to entry into acute phase: antipsychotics within 3 months, fluoxetine within 1 month, maois within 2 weeks, other antidepressant or mood-stabilizer (lithium, anticonvulsants) within 1 week.
boolean
C0040615 (UMLS CUI [1])
C0016365 (UMLS CUI [2])
C0026457 (UMLS CUI [3])
C0003289 (UMLS CUI [4])
C2917435 (UMLS CUI [5])
C3540800 (UMLS CUI [6])
C0003286 (UMLS CUI [7])
C0016365 (UMLS CUI [2])
C0026457 (UMLS CUI [3])
C0003289 (UMLS CUI [4])
C2917435 (UMLS CUI [5])
C3540800 (UMLS CUI [6])
C0003286 (UMLS CUI [7])
Study Subject Participation Status | Evaluation Investigator
Item
the investigator will evaluate whether there are other reasons why a patient may not participate.
boolean
C2348568 (UMLS CUI [1])
C1261322 (UMLS CUI [2,1])
C0035173 (UMLS CUI [2,2])
C1261322 (UMLS CUI [2,1])
C0035173 (UMLS CUI [2,2])